Early allograft dysfunction: Causes, recognition, and management

Liver Transplantation

Volumn 19, Issue SUPPL. 2, 2013, Pages

  Deschenes, Marc ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; METHYLPREDNISOLONE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; CAUSE OF DEATH; CYTOKINE RELEASE; EARLY ALLOGRAFT DYSFUNCTION; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER CELL DAMAGE; LIVER TRANSPLANTATION; MODEL FOR END STAGE LIVER DISEASE SCORE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION INJURY; RETRANSPLANTATION; RISK FACTOR;

ALLOGRAFTS; BIOLOGICAL MARKERS; CYTOKINES; END STAGE LIVER DISEASE; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MODELS, STATISTICAL; PATIENT SELECTION; PRIMARY GRAFT DYSFUNCTION; RISK FACTORS; TIME FACTORS; TISSUE DONORS;

EID: 84892405609     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23746     Document Type: Article

References (14)

1. Deschênes M, Belle SH, Krom RA, Zetterman RK, Lake JR. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transplantation 1998;66:302-310.
2. Mor E, Tillery W, Solomon H, Netto G, Watemberg I, Klintmalm GB. The predictive value of hepatocyte glycogen content on liver allograft biopsy. Correlation with early graft function. Transplantation 1995;59:141-143.
3. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, et al. Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993;55:807-813.
4. Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994;20(pt 1):829-838.
5. Olthoff KM, Kulik L, Samstein B, Kaminski M, Abecassis M, Emond J, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl 2010;16:943-949.
6. Clavien PA. Sinusoidal endothelial cell injury during hepatic preservation and reperfusion. Hepatology 1998;28:281-285.
7. Deschênes M, Forbes C, Tchervenkov J, Barkun J, Metrakos P, Tector J, Alpert E. Use of older donor livers is associated with more extensive ischemic damage on intraoperative biopsies during liver transplantation. Liver Transpl Surg 1999;5:357-361.
8. Bahde R, Spiegel HU. Hepatic ischaemia-reperfusion injury from bench to bedside. Br J Surg 2010;97:1461-1475.
9. Aldrighetti L, Pulitanò C, Arru M, Finazzi R, Catena M, Soldini L, et al. Impact of preoperative steroids administration on ischemia-reperfusion injury and systemic responses in liver surgery: a prospective randomized study. Liver Transpl 2006;12:941-949.
10. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6:783-790.
11. Ioannou GN. Development and validation of a model predicting graft survival after liver transplantation. Liver Transpl 2006;12:1594-1606.
12. Rana A, Hardy MA, Halazun KJ, Woodland DC, Ratner LE, Samstein B, et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant 2008;8:2537-2546.
13. Halldorson JB, Bakthavatsalam R, Fix O, Reyes JD, Perkins JD. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant 2009;9:318-326.
14. Friedman BH, Wolf JH, Wang L, Putt ME, Shaked A, Christie JD, et al. Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation. Liver Transpl 2012;18:166-176.